These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 25391436

  • 41. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C, Fisk JE, Wareing M, Murphy P.
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 47. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Morgan MJ.
    Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC, Parrott AC, Turner JJ.
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Visuospatial working memory impairment in current and previous ecstasy/polydrug users.
    Fisk JE, Montgomery C, Hadjiefthyvoulou F.
    Hum Psychopharmacol; 2011 Dec; 26(4-5):313-21. PubMed ID: 22700465
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Cowan RL, Joers JM, Dietrich MS.
    Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.